Hopefully that won't be a problem here, as I understand that the trial was designed in close consultation with the FDA. As well, there are two primary end points compared with the usual one.
Share Price, page-154
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.06 |
Change
-0.030(0.16%) |
Mkt cap ! $2.433B | |||
| Open | High | Low | Value | Volume |
| $19.08 | $19.42 | $18.54 | $4.293M | 224.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4002 | $19.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.11 | 448 | 1 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.10 |
Change
-0.030 ( 0.36 %) |
||||
| Open | High | Low | Volume | ||
| $19.13 | $19.41 | $18.95 | 87429 | ||
| Last updated 15.59pm 13/05/2024 ? | |||||
| NEU (ASX) Chart |